Nucore Inc. is a Houston-based medical device company resulting from a multi-year collaboration between J&J's Center for Medical Device Innovation @ The Texas Medical Center and California-based Precision Thoracic to innovate novel technologies focused on the early interception, diagnosis, and treatment of lung cancer. The American Cancer Society notes that "Lung cancer is by far the leading cause of cancer death among both men and women, making up almost 25% of all cancer deaths. More people die of lung cancer than of colon, breast, and prostate cancers combined." One reason that lung cancer is so lethal is that it is usually diagnosed late when it has already spread. There is a desperate...

Read More

Nucore Inc. is a Houston-based medical device company resulting from a multi-year collaboration between J&J's Center for Medical Device Innovation @ The Texas Medical Center and California-based Precision Thoracic to innovate novel technologies focused on the early interception, diagnosis, and treatment of lung cancer. The American Cancer Society notes that "Lung cancer is by far the leading cause of cancer death among both men and women, making up almost 25% of all cancer deaths. More people die of lung cancer than of colon, breast, and prostate cancers combined." One reason that lung cancer is so lethal is that it is usually diagnosed late when it has already spread. There is a desperate need to develop technologies to more effectively facilitate diagnosis and treatment of lung cancer at much earlier stages. Nucore has developed Minimally-invasive Targeted Resection (MiTR-core™), the first medical device designed to safely remove lung nodules in a simple, quick, and minimally invasive procedure. The MiTR-core procedure will enable clinicians to remove suspicious nodules upon initial detection, will provide a definitive diagnosis of the nodule, spare healthy lung tissue, and in the event of cancer, provide direct access to the site of the nodule for further targeted therapy. This CPRIT grant will significantly accelerate the commercialization of MiTR-core by the Houston-based Nucore team working in collaboration with clinical experts at MD Anderson Cancer Center.

Read Less